1992
DOI: 10.1007/bf00050916
|View full text |Cite
|
Sign up to set email alerts
|

Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction

Abstract: The aim of the study was to investigate the hemodynamic effects of a short-acting, potent, highly specific calcium antagonist, nisoldipine, in patients with acute myocardial infarction. Twenty-four patients were selected on the basis of an elevated wedge pressure and/or elevated blood pressure, less than 12 hours after the onset of symptoms. Patients were randomized to receive either placebo or low-dose nisoldipine (2 micrograms/kg) as a single intravenous injection over a 3-minute period. hemodynamic effects … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1993
1993
2000
2000

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…Although it has long been proposed that myocardial calcium overload can cause reperfusion damage after myocardial ischaemia, only recently has it been shown that some of this damage can specifically be inhibited by calcium channel antagonists added only at the time of reperfusion 171 . Some of this protection may be mediated by the newly described antioxidant properties of calcium channel antagonists' 81 . As will be discussed later, these properties must still be shown to be clinically relevant.…”
Section: Decreased Reperfusion Injury In Animal Modelsmentioning
confidence: 99%
“…Although it has long been proposed that myocardial calcium overload can cause reperfusion damage after myocardial ischaemia, only recently has it been shown that some of this damage can specifically be inhibited by calcium channel antagonists added only at the time of reperfusion 171 . Some of this protection may be mediated by the newly described antioxidant properties of calcium channel antagonists' 81 . As will be discussed later, these properties must still be shown to be clinically relevant.…”
Section: Decreased Reperfusion Injury In Animal Modelsmentioning
confidence: 99%